Literature DB >> 8206643

Doxycycline reduction of F-actin content of human neutrophils and fibroblasts.

W L Gabler1, J Smith, N Tsukuda.   

Abstract

We and others have shown that tetracyclines inhibit leukocyte adherence, migration, and phagocytosis, functions presumed to involve actin microfilament metabolism. In this study we investigated the influence of a tetracycline (doxycycline, Dc) on neutrophil and fibroblast actin metabolism. Human neutrophils and fibroblasts were pretreated with Dc or cytochalasin B (cB), stimulated with either the chemotactic peptide FMLP or phorbol myristate acetate (PMA), and the changes in phalloidin conjugate, associated F-actin were followed microscopically or quantified fluorometrically. Doxycycline suppressed, in a dose-related manner, the rise in F-actin content of neutrophils that normally follows their activation with either FMLP or PMA. Cytochalasin B had a similar affect on actin microfilament synthesis. Incubation of fibroblasts in Dc led to a loss of actin microfilaments and caused flattened adherent cells to round up and detach. Both Dc and cB also inhibited Con A-induced acceptor capping on neutrophils, a phenomenon known to be dependent on the presence of intact actin microfilaments. The data show that both Dc and cB influence actin metabolism and suggest they do so by differing mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206643     DOI: 10.1007/bf01534603

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  29 in total

1.  On the Mechanism of Action of Aureomycin.

Authors:  W F Loomis
Journal:  Science       Date:  1950-04-28       Impact factor: 47.728

2.  Phosphorylation and proteolytic modification of specific cytoskeletal proteins in human neutrophils stimulated by phorbol 12-myristate 13-acetate.

Authors:  S Pontremoli; E Melloni; M Michetti; B Sparatore; F Salamino; O Sacco; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

Review 3.  The biochemistry and the physiology of the tetracyclines: with special reference to mineralized tissues.

Authors:  K H Ibsen; M R Urist
Journal:  Clin Orthop Relat Res       Date:  1964 Jan-Feb       Impact factor: 4.176

Review 4.  Signal transduction and cytoskeletal activation in the neutrophil.

Authors:  G M Omann; R A Allen; G M Bokoch; R G Painter; A E Traynor; L A Sklar
Journal:  Physiol Rev       Date:  1987-01       Impact factor: 37.312

5.  Signal transduction and ligand-receptor dynamics in the neutrophil. Ca2+ modulation and restoration.

Authors:  L A Sklar; Z G Oades
Journal:  J Biol Chem       Date:  1985-09-25       Impact factor: 5.157

6.  Phorbol ester induces rapid actin assembly in neutrophil leucocytes independently of changes in [Ca2+]i and pHi.

Authors:  P Sheterline; J E Rickard; B Boothroyd; R C Richards
Journal:  J Muscle Res Cell Motil       Date:  1986-10       Impact factor: 2.698

7.  Phorbol myristate acetate induction of chemotactic migration of human polymorphonuclear neutrophils.

Authors:  W L Gabler; W W Bullock; H R Creamer
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

8.  Stimulation by chemotactic factor of actin association with the cytoskeleton in rabbit neutrophils. Effects of calcium and cytochalasin B.

Authors:  J R White; P H Naccache; R I Sha'afi
Journal:  J Biol Chem       Date:  1983-11-25       Impact factor: 5.157

9.  Tetracycline influence on leukocyte functions.

Authors:  J Belsheim; C Blomqvist; J Löfberg; H Gnarpe
Journal:  Acta Otorhinolaryngol Belg       Date:  1983

10.  Role of intracellular calcium mobilization in the regulation of protein kinase C-mediated membrane processes.

Authors:  W S May; N Sahyoun; M Wolf; P Cuatrecasas
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

View more
  1 in total

Review 1.  Immunomodulating effects of antibiotics: literature review.

Authors:  B Van Vlem; R Vanholder; P De Paepe; D Vogelaers; S Ringoir
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.